| Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
|
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
32.270 (91/282) |
1.22E-35 |
|
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
28.024 (95/339) |
8.53E-28 |
|
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
27.562 (78/283) |
3.73E-27 |
|
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
29.341 (98/334) |
3.26E-25 |
|
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
32.441 (97/299) |
4.68E-25 |
|
Omphalocele kinase 1 (NUAK1)
|
|
30.508 (72/236) |
4.71E-25 |
|
Polo-like kinase 4 (PLK4)
|
|
29.577 (84/284) |
2.15E-24 |
|
Serine/threonine-protein kinase 33 (STK33)
|
|
32.127 (71/221) |
4.41E-24 |
|
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
27.698 (77/278) |
5.02E-24 |
|
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
27.839 (76/273) |
6.26E-24 |
|
NIMA-related kinase 7 (NEK7)
|
|
28.374 (82/289) |
9.75E-24 |
|
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
27.839 (76/273) |
2.13E-23 |
|
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.474 (84/285) |
2.99E-23 |
|
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.615 (93/325) |
3.34E-23 |
|
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
32.189 (75/233) |
3.38E-23 |
|
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
24.503 (74/302) |
6.01E-23 |
|
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
27.815 (84/302) |
7.16E-23 |
|
NIMA-related kinase 6 (NEK6)
|
|
26.948 (83/308) |
8.29E-23 |
|
Aurora kinase A (AURKA)
|
|
25.806 (72/279) |
8.72E-23 |
|
NIMA-related kinase 1 (NEK1)
|
|
26.335 (74/281) |
1.01E-22 |
|
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
32.314 (74/229) |
3.31E-22 |
|
Microtubule affinity regulating kinase 3 (MARK3)
|
|
31.330 (73/233) |
6.98E-22 |
|
Protein kinase C alpha (PRKCA)
|
|
28.148 (76/270) |
8.85E-22 |
|
Myosin light chain kinase 3 (MYLK3)
|
|
31.225 (79/253) |
9.52E-22 |
|
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
27.113 (77/284) |
2.59E-21 |
|
STE20-related serine/threonine-protein kinase (SLK)
|
|
27.273 (75/275) |
3.13E-21 |
|
Serine/threonine-protein kinase 25 (STK25)
|
|
28.832 (79/274) |
3.37E-21 |
|
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
29.412 (75/255) |
4.27E-21 |
|
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
29.915 (70/234) |
5.18E-21 |
|
Serine/threonine-protein kinase 24 (STK24)
|
|
28.053 (85/303) |
5.30E-21 |
|
SNF-related serine/threonine-protein kinase (SNRK)
|
|
26.642 (73/274) |
5.68E-21 |
|
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
30.333 (91/300) |
6.11E-21 |
|
Serine/threonine-protein kinase 10 (STK10)
|
|
28.364 (78/275) |
6.55E-21 |
|
PKC-delta-interacting protein kinase (RIPK4)
|
|
30.035 (85/283) |
6.97E-21 |
|
Protein kinase C theta (PRKCQ)
|
|
28.226 (70/248) |
8.48E-21 |
|
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
29.185 (68/233) |
1.12E-20 |
|
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
29.694 (68/229) |
1.60E-20 |
|
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
30.804 (69/224) |
1.85E-20 |
|
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
25.658 (78/304) |
1.94E-20 |
|
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
29.911 (67/224) |
2.16E-20 |
|
Serine/threonine-protein kinase H1 (PSKH1)
|
|
31.618 (86/272) |
2.45E-20 |
|
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
29.502 (77/261) |
2.63E-20 |
|
Myosin light chain kinase family member 4 (MYLK4)
|
|
29.600 (74/250) |
3.56E-20 |
|
Protein kinase C beta (PRKCB)
|
|
29.646 (67/226) |
3.92E-20 |
|
PAK-1 protein kinase (PAK1)
|
|
27.798 (77/277) |
4.32E-20 |
|
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.685 (72/251) |
6.90E-20 |
|
Protein kinase C eta type (PRKCH)
|
|
29.614 (69/233) |
6.95E-20 |
|
Myosin light chain kinase 2 (MYLK2)
|
|
30.088 (68/226) |
7.20E-20 |
|
Myosin light kinase (MYLK)
|
|
26.087 (60/230) |
9.02E-20 |
|
Death-associated protein kinase 3 (DAPK3)
|
|
29.956 (68/227) |
1.25E-19 |
|
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
27.798 (77/277) |
1.41E-19 |
|
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
27.519 (71/258) |
1.51E-19 |
|
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
29.956 (68/227) |
1.51E-19 |
|
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
28.205 (66/234) |
1.96E-19 |
|
PAK-2 protein kinase (PAK2)
|
|
27.076 (75/277) |
3.10E-19 |
|
Cyclin-dependent kinase 1 (CDK1)
|
|
32.143 (72/224) |
3.56E-19 |
|
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
30.357 (68/224) |
3.81E-19 |
|
Serine/threonine-protein kinase 26 (STK26)
|
|
27.541 (84/305) |
4.11E-19 |
|
Fused homolog (STK36)
|
|
26.974 (82/304) |
4.33E-19 |
|
Salt-inducible kinase 2 (SIK2)
|
|
32.340 (76/235) |
5.21E-19 |
|
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
28.846 (75/260) |
5.56E-19 |
|
TAO kinase 3 (TAOK3)
|
|
28.782 (78/271) |
5.98E-19 |
|
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
28.959 (64/221) |
6.43E-19 |
|
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
26.480 (85/321) |
8.69E-19 |
|
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
28.777 (80/278) |
9.36E-19 |
|
TAO kinase 1 (TAOK1)
|
|
26.715 (74/277) |
1.03E-18 |
|
Unc-51 like kinase 3 (ULK3)
|
|
28.623 (79/276) |
1.14E-18 |
|
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
26.667 (72/270) |
1.18E-18 |
|
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
27.490 (69/251) |
1.31E-18 |
|
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
25.490 (78/306) |
1.67E-18 |
|
MST-1 protein kinase (STK4)
|
|
24.911 (70/281) |
1.82E-18 |
|
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
29.515 (67/227) |
2.14E-18 |
|
Myosin-IIIb (MYO3B)
|
|
27.667 (83/300) |
2.19E-18 |
|
SIK family kinase 3 (SIK3)
|
|
29.630 (72/243) |
2.52E-18 |
|
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
28.767 (63/219) |
2.62E-18 |
|
Doublecortin-like kinase 3 (DCLK3)
|
|
27.500 (66/240) |
3.07E-18 |
|
Checkpoint kinase-1 (CHK1)
|
|
29.825 (68/228) |
3.57E-18 |
|
Cyclin-dependent kinase 3 (CDK3)
|
|
30.804 (69/224) |
3.60E-18 |
|
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
26.122 (64/245) |
3.97E-18 |
|
Polo-like kinase 2 (PLK2)
|
|
25.168 (75/298) |
4.35E-18 |
|
Serine/threonine-protein kinase 3 (STK3)
|
|
24.555 (69/281) |
5.16E-18 |
|
ERK activator kinase 1 (MEK1)
|
|
27.103 (58/214) |
5.18E-18 |
|
ERK activator kinase 5 (MAP2K5)
|
|
25.806 (72/279) |
5.61E-18 |
|
Death-associated protein kinase 2 (DAPK2)
|
|
29.956 (68/227) |
5.72E-18 |
|
ERK activator kinase 2 (MEK2)
|
|
29.911 (67/224) |
5.85E-18 |
|
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
28.440 (62/218) |
5.85E-18 |
|
Doublecortin-like kinase 1 (DCLK1)
|
|
30.396 (69/227) |
7.11E-18 |
|
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
27.200 (68/250) |
7.18E-18 |
|
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
28.767 (63/219) |
7.20E-18 |
|
MEK kinase kinase 2 (MAP4K2)
|
|
29.148 (65/223) |
7.43E-18 |
|
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
28.814 (68/236) |
8.39E-18 |
|
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
27.817 (79/284) |
8.81E-18 |
|
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
27.686 (67/242) |
9.67E-18 |
|
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
28.571 (80/280) |
1.04E-17 |
|
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
27.459 (67/244) |
1.05E-17 |
|
Protein kinase N1 (PKN1)
|
|
27.899 (77/276) |
1.08E-17 |
|
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
24.409 (62/254) |
1.27E-17 |
|
BR serine/threonine kinase 1 (BRSK1)
|
|
28.821 (66/229) |
1.33E-17 |
|
MEK kinase kinase 3 (MAP4K3)
|
|
29.148 (65/223) |
1.34E-17 |
|
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
29.915 (70/234) |
1.70E-17 |
|
Protein kinase N2 (PKN2)
|
|
28.571 (70/245) |
1.83E-17 |
|
Protein kinase D (PRKD1)
|
|
27.727 (61/220) |
2.30E-17 |
|
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
25.792 (57/221) |
2.42E-17 |
|
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
25.649 (79/308) |
2.58E-17 |
|
Aurora kinase C (AURKC)
|
|
27.004 (64/237) |
2.79E-17 |
|
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
28.390 (67/236) |
3.24E-17 |
|
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
26.277 (72/274) |
3.27E-17 |
|
Cyclin-dependent kinase 10 (CDK10)
|
|
35.426 (79/223) |
4.11E-17 |
|
Salt-inducible kinase 1 (SIK1)
|
|
29.268 (72/246) |
4.35E-17 |
|
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
29.268 (72/246) |
4.46E-17 |
|
Peripheral plasma membrane protein CASK (CASK)
|
|
30.769 (72/234) |
4.93E-17 |
|
Protein kinase C gamma (PRKCG)
|
|
26.054 (68/261) |
5.29E-17 |
|
Maternal embryonic leucine zipper kinase (MELK)
|
|
26.667 (76/285) |
5.43E-17 |
|
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
26.038 (69/265) |
6.13E-17 |
|
Serine/threonine-protein kinase D3 (PRKD3)
|
|
28.182 (62/220) |
6.37E-17 |
|
Death-associated protein kinase 1 (DAPK1)
|
|
28.571 (64/224) |
6.59E-17 |
|
Protein kinase C epsilon (PRKCE)
|
|
25.431 (59/232) |
6.71E-17 |
|
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
28.214 (79/280) |
7.19E-17 |
|
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
26.471 (63/238) |
9.19E-17 |
|
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
27.572 (67/243) |
9.56E-17 |
|
Serine/threonine-protein kinase D2 (PRKD2)
|
|
28.636 (63/220) |
1.17E-16 |
|
Doublecortin-like kinase 2 (DCLK2)
|
|
24.561 (84/342) |
1.27E-16 |
|
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
26.050 (62/238) |
1.35E-16 |
|
Cyclin-dependent kinase 2 (CDK2)
|
|
29.130 (67/230) |
1.36E-16 |
|
Oxidative stress responsive 1 (OXSR1)
|
|
24.342 (74/304) |
1.39E-16 |
|
Protein kinase C delta (PRKCD)
|
|
27.706 (64/231) |
1.39E-16 |
|
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
27.803 (62/223) |
1.46E-16 |
|
PDZ binding kinase (PBK)
|
|
25.692 (65/253) |
1.51E-16 |
|
BR serine/threonine kinase 2 (BRSK2)
|
|
28.700 (64/223) |
1.54E-16 |
|
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
27.917 (67/240) |
1.75E-16 |
|
Protein kinase G2 (PRKG2)
|
|
28.000 (70/250) |
1.79E-16 |
|
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
29.515 (67/227) |
1.84E-16 |
|
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
26.756 (80/299) |
2.21E-16 |
|
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
26.335 (74/281) |
2.48E-16 |
|
Myosin-IIIa (MYO3A)
|
|
26.421 (79/299) |
2.66E-16 |
|
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
25.000 (66/264) |
3.05E-16 |
|
ERK activator kinase 7 (MAP2K7)
|
|
27.113 (77/284) |
3.81E-16 |
|
Beta-adrenergic receptor kinase 2 (ADRBK2)
|
|
24.528 (65/265) |
3.94E-16 |
|
Aurora kinase B (AURKB)
|
|
25.185 (68/270) |
4.79E-16 |
|
MEK kinase kinase 1 (MAP4K1)
|
|
25.417 (61/240) |
4.97E-16 |
|
Stress-activated protein kinase 2a (p38 alpha)
|
|
31.739 (73/230) |
5.13E-16 |
|
Ste-20-related kinase (STK39)
|
|
25.510 (75/294) |
5.31E-16 |
|
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
29.091 (64/220) |
5.82E-16 |
|
TRAF2 and NCK interacting kinase (TNIK)
|
|
27.119 (64/236) |
6.41E-16 |
|
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
27.966 (66/236) |
6.61E-16 |
|
Obscurin (OBSCN)
|
|
28.832 (79/274) |
7.01E-16 |
|
Serine/threonine-protein kinase STK11 (STK11)
|
|
26.429 (74/280) |
8.85E-16 |
|
TGF-beta receptor type I (TGFBR1)
|
|
29.518 (98/332) |
1.10E-15 |
|
Cyclin-dependent kinase 5 (CDK5)
|
|
28.311 (62/219) |
1.24E-15 |
|
NIMA-related kinase 2 (NEK2)
|
|
26.509 (101/381) |
1.27E-15 |
|
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
29.091 (64/220) |
1.29E-15 |
|
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
28.319 (64/226) |
1.61E-15 |
|
Polo-like kinase 1 (PLK1)
|
|
26.117 (76/291) |
1.85E-15 |
|
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
25.926 (63/243) |
2.13E-15 |
|
Serine/threonine-protein kinase 17B (STK17B)
|
|
29.310 (68/232) |
2.55E-15 |
|
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
28.125 (63/224) |
2.63E-15 |
|
Serine/threonine-protein kinase H2 (PSKH2)
|
|
29.258 (67/229) |
2.72E-15 |
|
PAK-4 protein kinase (PAK4)
|
|
28.767 (63/219) |
3.22E-15 |
|
Misshapen-like kinase 1 (MINK1)
|
|
27.119 (64/236) |
3.88E-15 |
|
Cyclin-dependent kinase 7 (CDK7)
|
|
28.821 (66/229) |
4.66E-15 |
|
Protein kinase C iota (PRKCI)
|
|
24.675 (57/231) |
5.61E-15 |
|
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
26.502 (75/283) |
1.36E-14 |
|
Cyclin-dependent kinase 15 (CDK15)
|
|
27.881 (75/269) |
1.39E-14 |
|
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
26.364 (58/220) |
1.50E-14 |
|
G protein-coupled receptor kinase 6 (GRK6)
|
|
30.631 (68/222) |
1.64E-14 |
|
Serine/threonine-protein kinase NLK (NLK)
|
|
30.357 (68/224) |
1.69E-14 |
|
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
28.185 (73/259) |
1.70E-14 |
|
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
23.774 (63/265) |
1.73E-14 |
|
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
26.957 (62/230) |
1.84E-14 |
|
Cyclin-dependent kinase 6 (CDK6)
|
|
26.316 (60/228) |
2.40E-14 |
|
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
33.951 (55/162) |
2.44E-14 |
|
Cyclin-dependent kinase 17 (CDK17)
|
|
29.130 (67/230) |
2.61E-14 |
|
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
24.242 (64/264) |
2.64E-14 |
|
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
25.379 (67/264) |
2.70E-14 |
|
Cyclin-dependent kinase 11B (CDK11B)
|
|
28.516 (73/256) |
2.91E-14 |
|
Cytoplasmic DRAK1 (STK17A)
|
|
30.493 (68/223) |
3.58E-14 |
|
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
30.290 (73/241) |
4.59E-14 |
|
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
28.326 (66/233) |
4.60E-14 |
|
MAP kinase p38 (MAPK12)
|
|
30.651 (80/261) |
5.59E-14 |
|
Protein kinase N3 (PKN3)
|
|
27.972 (80/286) |
6.02E-14 |
|
Cyclin-dependent kinase 16 (CDK16)
|
|
28.270 (67/237) |
6.47E-14 |
|
Serine/threonine-protein kinase MAK (MAK)
|
|
26.761 (57/213) |
6.49E-14 |
|
Rhodopsin kinase GRK7 (GRK7)
|
|
26.697 (59/221) |
7.72E-14 |
|
Protein kinase C zeta (PRKCZ)
|
|
24.786 (58/234) |
7.96E-14 |
|
Cyclin-dependent kinase 14 (CDK14)
|
|
26.712 (78/292) |
8.62E-14 |
|
Calmodulin-dependent kinase II (CAMKK2)
|
|
26.840 (62/231) |
8.76E-14 |
|
Cyclin-dependent kinase 11A (CDK11A)
|
|
29.439 (63/214) |
9.06E-14 |
|
MEK kinase kinase 4 (MAP4K4)
|
|
26.695 (63/236) |
1.04E-13 |
|
Cyclin-dependent kinase 13 (CDK13)
|
|
24.917 (75/301) |
1.26E-13 |
|
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
28.384 (65/229) |
1.30E-13 |
|
Cyclin-dependent kinase 4 (CDK4)
|
|
28.755 (67/233) |
1.39E-13 |
|
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
26.939 (66/245) |
1.54E-13 |
|
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
28.509 (65/228) |
1.89E-13 |
|
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
28.821 (66/229) |
1.92E-13 |
|
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
27.155 (63/232) |
2.19E-13 |
|
Serine/threonine-protein kinase ICK (CILK1)
|
|
26.047 (56/215) |
2.25E-13 |
|
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
27.984 (68/243) |
2.32E-13 |
|
Cyclin-dependent kinase 18 (CDK18)
|
|
27.106 (74/273) |
2.47E-13 |
|
Cyclin-dependent kinase 12 (CDK12)
|
|
24.503 (74/302) |
2.60E-13 |
|
Serine/threonine-protein kinase 32A (STK32A)
|
|
26.923 (63/234) |
2.83E-13 |
|
Activin receptor type IB (ACVR1B)
|
|
30.417 (73/240) |
2.88E-13 |
|
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
28.870 (69/239) |
3.29E-13 |
|
G protein-coupled receptor kinase 5 (GRK5)
|
|
29.464 (66/224) |
3.91E-13 |
|
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
23.767 (53/223) |
4.25E-13 |
|
Mitogen-activated protein kinase 13 (MAPK13)
|
|
29.796 (73/245) |
6.13E-13 |
|
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
27.197 (65/239) |
6.15E-13 |
|
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.959 (64/221) |
6.52E-13 |
|
TGF-beta-stimulated factor 1 (STK16)
|
|
24.832 (74/298) |
7.56E-13 |
|
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
25.203 (62/246) |
8.47E-13 |
|
MAPK-activated protein kinase 3 (MAPKAPK3)
|
|
26.201 (60/229) |
1.16E-12 |
|
Rho-associated protein kinase 1 (ROCK1)
|
|
26.054 (68/261) |
1.43E-12 |
|
Stress-activated protein kinase JNK2 (JNK2)
|
|
32.444 (73/225) |
1.45E-12 |
|
Stress-activated protein kinase 2b (p38 beta)
|
|
29.771 (78/262) |
1.72E-12 |
|
Cyclin-dependent kinase 19 (CDK19)
|
|
29.515 (67/227) |
2.07E-12 |
|
Extracellular signal-regulated kinase 1 (ERK1)
|
|
27.397 (60/219) |
2.34E-12 |
|
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
25.431 (59/232) |
2.45E-12 |
|
Protein kinase G1 (PRKG1)
|
|
24.444 (66/270) |
2.62E-12 |
|
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
25.463 (55/216) |
3.20E-12 |
|
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
27.197 (65/239) |
3.50E-12 |
|
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
39.048 (41/105) |
3.58E-12 |
|
G protein-coupled receptor kinase 4 (GRK4)
|
|
28.378 (63/222) |
3.60E-12 |
|
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
27.897 (65/233) |
4.12E-12 |
|
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
25.431 (59/232) |
4.22E-12 |
|
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
26.977 (58/215) |
5.37E-12 |
|
CaM-kinase IV kinase (CAMKK1)
|
|
27.273 (63/231) |
1.05E-11 |
|
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
26.923 (77/286) |
1.16E-11 |
|
Activin receptor type IIA (ACVR2A)
|
|
25.857 (83/321) |
1.22E-11 |
|
Cyclin-dependent kinase 8 (CDK8)
|
|
29.204 (66/226) |
1.29E-11 |
|
Titin (TTN)
|
24.138 (56/232) |
1.48E-11 |
|
SH3 domain-containing protein 21 (SH3D21)
|
|
45.902 (28/61) |
1.57E-11 |
|
Serine/threonine-protein kinase 35 (STK35)
|
|
24.935 (96/385) |
1.61E-11 |
|
Nik-related protein kinase (NRK)
|
|
23.323 (73/313) |
1.62E-11 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
27.848 (66/237) |
1.66E-11 |
|
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
29.534 (57/193) |
2.26E-11 |
|
Serine/threonine-protein kinase MRCK gamma (CDC42BPG)
|
|
26.016 (64/246) |
2.42E-11 |
|
Stress-activated protein kinase JNK3 (JNK3)
|
|
30.159 (76/252) |
3.88E-11 |
|
Rho-associated protein kinase 2 (ROCK2)
|
|
24.138 (63/261) |
3.89E-11 |
|
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
25.368 (69/272) |
4.53E-11 |
|
Cyclin-G-associated kinase (GAK)
|
|
24.762 (78/315) |
4.66E-11 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
26.360 (63/239) |
5.22E-11 |
|
Extracellular signal-regulated kinase 5 (ERK5)
|
|
25.862 (60/232) |
5.94E-11 |
|
Triple functional domain protein (TRIO)
|
|
27.106 (74/273) |
6.35E-11 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
28.879 (67/232) |
6.61E-11 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
28.033 (67/239) |
6.66E-11 |
|
Mitogen-activated protein kinase 15 (MAPK15)
|
|
29.583 (71/240) |
7.13E-11 |
|
GRB2-related adapter protein 2 (GRAP2)
|
|
49.231 (32/65) |
7.16E-11 |
|
Rhodopsin kinase GRK1 (GRK1)
|
|
26.906 (60/223) |
7.55E-11 |
|
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
28.696 (66/230) |
1.03E-10 |
|
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
29.444 (53/180) |
1.06E-10 |
|
Serine/threonine-protein kinase 32C (STK32C)
|
|
26.050 (62/238) |
1.39E-10 |
|
Bone morphogenetic protein receptor (BMPR2)
|
|
24.803 (63/254) |
1.46E-10 |
|
Yet another novel kinase 2 (STK32B)
|
|
25.957 (61/235) |
1.61E-10 |
|
Stress-activated protein kinase JNK1 (JNK1)
|
|
29.365 (74/252) |
1.75E-10 |
|
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
26.222 (59/225) |
1.76E-10 |
|
Citron Rho-interacting kinase (CIT)
|
|
27.119 (64/236) |
2.47E-10 |
|
Serine/threonine-protein kinase cot (COT)
|
|
25.267 (71/281) |
2.48E-10 |
|
Cyclin-dependent kinase 9 (CDK9)
|
|
26.407 (61/231) |
2.57E-10 |
|
NF-kappa-B-activating kinase (TBK1)
|
|
25.316 (60/237) |
2.91E-10 |
|
Dual specificity protein kinase TTK (MPS1)
|
|
22.807 (65/285) |
3.10E-10 |
|
Serine/threonine-protein kinase ULK4 (ULK4)
|
|
23.473 (73/311) |
4.41E-10 |
|
Anti-mullerian hormone II receptor (AMHR2)
|
|
27.151 (101/372) |
4.63E-10 |
|
Testis-specific serine kinase 2 (TSSK2)
|
|
25.446 (57/224) |
7.50E-10 |
|
Activin receptor type IIB (ACVR2B)
|
|
28.340 (70/247) |
8.89E-10 |
|
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
24.138 (56/232) |
1.08E-09 |
|
CDC-like kinase 1 (CLK1)
|
|
27.160 (66/243) |
1.11E-09 |
|
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
26.638 (61/229) |
1.41E-09 |
|
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
25.683 (47/183) |
1.44E-09 |
|
Serine/threonine-protein kinase MRCK beta (CDC42BPB)
|
|
24.046 (63/262) |
1.63E-09 |
|
CDC42 binding protein kinase alpha (DMPK-like alpha)
|
|
24.427 (64/262) |
2.49E-09 |
|
Adaptor-associated kinase 1 (AAK1)
|
|
22.483 (67/298) |
2.71E-09 |
|
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
30.220 (55/182) |
3.82E-09 |
|
Mitogen-activated protein kinase 6 (MAPK6)
|
|
26.638 (61/229) |
4.26E-09 |
|
CDC-like kinase 4 (CLK4)
|
|
25.651 (69/269) |
5.18E-09 |
|
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
25.342 (74/292) |
6.62E-09 |
|
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
26.522 (61/230) |
7.02E-09 |
|
MAP kinase signal-integrating kinase 2 (MKNK2)
|
|
26.271 (62/236) |
7.46E-09 |
|
Interleukin-1 receptor-associated kinase-like 2 (IRAK2)
|
|
28.634 (65/227) |
7.54E-09 |
|
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
26.786 (60/224) |
1.26E-08 |
|
CDC-like kinase 3 (CLK3)
|
|
24.907 (67/269) |
1.30E-08 |
|
Wee1-like protein kinase 2 (WEE2)
|
|
23.311 (69/296) |
1.52E-08 |
|
Tau-tubulin kinase (TTBK1)
|
|
22.867 (67/293) |
2.27E-08 |
|
MAPK-activated protein kinase 5 (MAPKAPK5)
|
|
25.366 (52/205) |
2.30E-08 |
|
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
22.264 (59/265) |
2.34E-08 |
|
Mitogen-activated protein kinase 4 (MAPK4)
|
|
35.398 (40/113) |
2.49E-08 |
|
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
23.810 (55/231) |
3.87E-08 |
|
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
27.074 (62/229) |
5.13E-08 |
|
Proto-oncogene vav (VAV1)
|
|
43.860 (25/57) |
5.40E-08 |
|
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
26.923 (63/234) |
5.45E-08 |
|
Serine/threonine-protein kinase/endoribonuclease IRE2 (ERN2)
|
|
28.634 (65/227) |
8.03E-08 |
|
CDC-like kinase 2 (CLK2)
|
|
23.420 (63/269) |
9.58E-08 |
|
Guanine nucleotide exchange factor VAV2 (VAV2)
|
|
43.860 (25/57) |
9.93E-08 |
|
Serine/threonine-protein kinase greatwall (MASTL)
|
|
24.607 (47/191) |
1.06E-07 |
|
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
31.200 (39/125) |
1.23E-07 |
|
Signal transducing adapter molecule 2 (STAM2)
|
|
39.623 (21/53) |
1.35E-07 |
|
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
23.789 (54/227) |
1.64E-07 |
|
Serine/threonine-protein kinase 40 (STK40)
|
|
24.859 (44/177) |
1.77E-07 |
|
Myotonin-protein kinase (DMPK)
|
|
24.125 (62/257) |
2.01E-07 |
|
NDR1 protein kinase (STK38)
|
|
21.887 (58/265) |
3.25E-07 |
|
Wee1-like protein kinase (WEE1)
|
|
23.693 (68/287) |
4.87E-07 |
|
MAPK signal-integrating kinase 1 (MKNK1)
|
|
25.940 (69/266) |
5.09E-07 |
|
Large tumor suppressor homolog 2 (LATS2)
|
|
21.927 (66/301) |
5.12E-07 |
|
Guanine nucleotide exchange factor VAV3 (VAV3)
|
|
32.653 (32/98) |
5.20E-07 |
|
Signal transducing adapter molecule 1 (STAM)
|
|
35.849 (19/53) |
6.17E-07 |
|
Jouberin (AHI1)
|
|
37.838 (28/74) |
6.98E-07 |
|
NDR2 protein kinase (STK38L)
|
|
22.642 (60/265) |
7.24E-07 |
|
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
25.514 (62/243) |
8.36E-07 |
|
PIM-3 protein kinase (PIM3)
|
|
29.885 (26/87) |
1.02E-06 |
|
Cyclin-dependent kinase 20 (CDK20)
|
|
27.200 (68/250) |
1.03E-06 |
|
Tau-tubulin kinase 2 (TTBK2)
|
|
24.481 (59/241) |
1.17E-06 |
|
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
21.967 (67/305) |
1.25E-06 |
|
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
35.135 (39/111) |
1.31E-06 |
|
Kalirin (KALRN)
|
|
25.180 (70/278) |
1.61E-06 |
|
Abl interactor 1 (ABI1)
|
|
38.889 (21/54) |
1.86E-06 |
|
BMP-2-inducible protein kinase (BMP2K)
|
|
22.789 (67/294) |
2.03E-06 |
|
TBC domain-containing protein kinase-like protein (TBCK)
|
|
23.171 (57/246) |
2.28E-06 |
|
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
29.655 (43/145) |
3.26E-06 |
|
Growth factor receptor-bound protein 2 (GRB2)
|
|
36.364 (20/55) |
4.71E-06 |
|
Rho guanine nucleotide exchange factor 7 (ARHGEF7)
|
|
32.836 (22/67) |
4.79E-06 |
|
Unconventional myosin-Ie (MYO1E)
|
|
37.037 (20/54) |
5.12E-06 |
|
Hematopoietic lineage cell-specific protein (HCLS1)
|
|
41.509 (22/53) |
5.93E-06 |
|
Breast cancer anti-estrogen resistance protein 1 (BCAR1)
|
|
46.296 (25/54) |
6.12E-06 |
|
SH3 domain-containing protein 19 (SH3D19)
|
|
39.623 (21/53) |
9.32E-06 |
|
Rho guanine nucleotide exchange factor 6 (ARHGEF6)
|
|
25.000 (27/108) |
1.09E-05 |
|
STE20-related kinase adapter protein alpha (STRADA)
|
|
23.377 (54/231) |
1.48E-05 |
|
Ribosomal protein S6 kinase-like 1 (RPS6KL1)
|
|
30.000 (45/150) |
1.55E-05 |
|
Unconventional myosin-If (MYO1F)
|
|
39.623 (21/53) |
1.56E-05 |
|
GRB2-related adapter protein (GRAP)
|
|
39.063 (25/64) |
1.68E-05 |
|
Src kinase-associated phosphoprotein 2 (SKAP2)
|
|
29.730 (22/74) |
1.76E-05 |
|
Dedicator of cytokinesis protein 1 (DOCK1)
|
|
43.860 (25/57) |
1.88E-05 |
|
STE20-related kinase adapter protein beta (STRADB)
|
|
22.636 (79/349) |
3.13E-05 |
|
Endophilin-A1 (SH3GL2)
|
|
31.169 (24/77) |
3.72E-05 |
|
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (PLCG2)
|
|
41.667 (25/60) |
3.78E-05 |
|
SH3 and PX domain-containing protein 2B (SH3PXD2B)
|
|
38.182 (21/55) |
5.36E-05 |
|
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
26.957 (62/230) |
5.68E-05 |
|
Spectrin alpha chain, non-erythrocytic 1 (SPTAN1)
|
|
33.333 (23/69) |
5.78E-05 |
|
Ribosomal protein S6 kinase delta-1 (RPS6KC1)
|
|
27.742 (43/155) |
6.19E-05 |
|
Endophilin-A3 (SH3GL3)
|
|
28.395 (23/81) |
6.41E-05 |
|
Membrane-associated kinase (PKMYT1)
|
|
25.287 (66/261) |
6.93E-05 |
|
NADPH oxidase activator 1 (NOXA1)
|
|
37.500 (24/64) |
8.58E-05 |
|
Osteoclast-stimulating factor 1 (OSTF1)
|
|
35.088 (20/57) |
1.30E-04 |
|
SH3 and multiple ankyrin repeat domains protein 1 (SHANK1)
|
|
39.623 (21/53) |
1.60E-04 |
|
Src kinase-associated phosphoprotein 1 (SKAP1)
|
|
33.898 (20/59) |
3.47E-04 |
|
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
29.060 (34/117) |
4.33E-04 |
|
Spectrin alpha chain, erythrocytic 1 (SPTA1)
|
|
30.488 (25/82) |
5.49E-04 |
| Click to Show/Hide the Information of Human Similarity Proteins |
